Bayer AG Faces Significant Drop After Legal Setback

In a dramatic start to the week, Bayer AG witnessed a sharp decline of over 6% in early trading on Monday. This downturn comes in the wake of a damaging legal verdict in the United States, where a Georgia jury ruled against Monsanto Co., a subsidiary of Bayer. The jury ordered Monsanto to pay more than $2 billion in damages to a plaintiff who alleged that the company's herbicide, Roundup, was responsible for his cancer.

Market Reaction to the Verdict

By 9:05 am CET, Bayer's shares had plummeted by 6.83%, trading at €22.49. This significant drop reflects the market's reaction to the legal and financial implications of the verdict for Bayer and its subsidiary, Monsanto.